HARMON CYRUS (Chief Technology Officer) sold 0.5% of their position (3.49K shares) of OLEMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $101.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/16/2026ACC: 0001831410-26-000002
DirectorOfficer· Chief Technology Officer
Since Nov 2020
-3.49K
Net shares
Net seller
$101.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.49K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.49K
Price / share
$29.12
Trade value
$101.60K
% of position
0.5%
1/14/2026
741.26K→737.77K
Total
Net shares
−3.49K
Net value
-$101.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/14/2026 | S · Sale | −3.49K | $29.12 | $101.60K | 0.5% | 741.26K | 737.77K |
| Total | −3.49K | -$101.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned117.03K
Total
117.03K indirect117.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 117.03K | Indirect |
| Total | 117.03K | 117.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported